32 Recruiting Breast Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Breast Cancer studiesPhase 1 / Phase 2 Studies for Breast Cancer
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)
📍 Stanford Women's Cancer Center — Palo Alto, California
View Study & Checklist ➔CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
📍 BCCA - Vancouver Cancer Centre — Vancouver, British Columbia
View Study & Checklist ➔Breast Cancer Study of Preoperative Pembrolizumab + Radiation
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
📍 Univ of California at San Diego Moores Cancer Ctr — San Diego, California
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
📍 Highlands Oncology Group — Fayetteville, Arkansas
View Study & Checklist ➔Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
📍 Dothan Hematology and Oncology — Dothan, Alabama
View Study & Checklist ➔A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
📍 Highlands Oncology — Fayetteville, Arkansas
View Study & Checklist ➔Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy
📍 Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania
View Study & Checklist ➔Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
📍 Administrative Address: UCLA Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
📍 MedStar Georgetown University Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
📍 Stanford Women's Cancer Center — Palo Alto, California
View Study & Checklist ➔Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations
📍 New York Presbyterian Hospital - Queens — New York, New York
View Study & Checklist ➔Onvansertib + Paclitaxel In TNBC
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
📍 UCLA Medical Center — Los Angeles, California
View Study & Checklist ➔FMT in Triple Negative Breast Cancer Guided by ctDNA
📍 London Health Sciences Center — London, Ontario
View Study & Checklist ➔Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
📍 Florida Cancer Specialists — Orlando, Florida
View Study & Checklist ➔Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔VS-6766+Abema+Fulv in Met HR+/HER- BC
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
📍 Sarcoma Oncology Center — Santa Monica, California
View Study & Checklist ➔A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
📍 Ellison Clinic at Saint John's — Los Angeles, California
View Study & Checklist ➔A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
📍 Research Site — Duarte, California
View Study & Checklist ➔A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
📍 Southern Cancer Center, PC — Daphne, Alabama
View Study & Checklist ➔HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
📍 Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey
View Study & Checklist ➔A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
📍 City of Hope — Duarte, California
View Study & Checklist ➔Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
📍 Mount Sinai Beth Israel — New York, New York
View Study & Checklist ➔